Cartesian Therapeutics Inc. (RNAC) — Tangible Net Worth Ratio
Cartesian Therapeutics Inc. (RNAC) has a Tangible Net Worth Ratio of -19926.6% as of September 2024. This metric is calculated by deducting intangible assets ($150.60 Million) from net assets ($752.00K) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Also explore Cartesian Therapeutics Inc. (RNAC) equity growth momentum to track the company's year-over-year net asset growth rate.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Cartesian Therapeutics Inc. Tangible Net Worth Ratio (2016–2022)
This chart shows how Cartesian Therapeutics Inc.'s Tangible Net Worth Ratio has changed across 5 annual periods from 2016 to 2022. As of September 2024, the ratio stands at -19926.6%, reflecting net assets of $752.00K with intangible assets of $150.60 Million USD. Check asset allocation strategy of Cartesian Therapeutics Inc. to assess the company's strategic physical and investment asset allocation.
Annual Tangible Net Worth Ratio for Cartesian Therapeutics Inc. (2016–2022)
The table below presents the year-by-year Tangible Net Worth Ratio for Cartesian Therapeutics Inc. from 2016 to 2022, covering 5 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For live market cap and overall valuation, see RNAC market cap.
| Year | Tangible NW Ratio | Net Assets (USD) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2022 | 100.0% | $93.83 Million | $0.00 | $165.89 Million | ▲ +0.0 pp |
| 2021 | 100.0% | $22.52 Million | $0.00 | $159.88 Million | ▲ +0.0 pp |
| 2019 | 100.0% | $8.40 Million | $0.00 | $99.57 Million | ▲ +0.0 pp |
| 2017 | 100.0% | $51.81 Million | $0.00 | $101.10 Million | ▲ +0.0 pp |
| 2016 | 100.0% | $54.96 Million | $0.00 | $89.30 Million | — |